Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 57.20
-1.20 (-2.05%)
Jul 17, 2026, 5:35 PM CET
Clínica Baviera Market Cap
Clínica Baviera has a market cap or net worth of €916.26 million as of July 17, 2026. Its market cap has increased by 29.81% in one year.
Market Cap
916.26M
Enterprise Value
936.07M
Revenue
304.91M
Ranking
n/a
PE Ratio
21.78
Stock Price
€57.20
ChartMarket Cap Chart
Since April 10, 2007, Clínica Baviera's market cap has increased from 369.53M to 916.26M, an increase of 147.95%. That is a compound annual growth rate of 4.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 916.26M | 15.14% |
| Dec 31, 2025 | 795.80M | 59.55% |
| Dec 31, 2024 | 498.78M | 33.02% |
| Dec 29, 2023 | 374.97M | 31.81% |
| Dec 30, 2022 | 284.48M | -17.68% |
| Dec 30, 2021 | 345.60M | 50.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.49B |
| Laboratorios Farmaceuticos Rovi | 2.75B |
| Almirall | 2.32B |
| Faes Farma | 1.37B |
| Pharma Mar | 1.32B |
| Oryzon Genomics | 237.84M |
| Prim, S.A. | 224.58M |
| Laboratorio Reig Jofre | 213.30M |